Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors by Cheng, J, Demeulemeester, J, Wedge, DC, Vollan, HKM, Pitt, JJ, Russnes, HG, Pandey, BP, Nilsen, G, Nord, S, Bignell, GR, White, KP, Børresen-Dale, AL, Campbell, PJ, Kristensen, VN, Stratton, MR, Lingjærde, OC, Moreau, Y, Loo, PV

Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations by Höglander, EK, Nord, S, Wedge, DC, Lingjærde, OC, Silwal-Pandit, L, Gythfeldt, HV, Vollan, HKM, Fleischer, T, Krohn, M, Schlitchting, E, Borgen, E, Garred, Ø, Holmen, MM, Wist, E, Naume, B, Van Loo, P, Børresen-Dale, A-L, Engebraaten, O, Kristensen, V